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multiple physiological pathways. NAEs are synthesized in 
vivo from respective fatty acid precursors, with the subse-
quent breakdown of NAEs to unesterified fatty acids occur-
ring via fatty acid amide hydrolase (FAAH) (1, 2). NAEs 
exhibit a wide range of biological functions. For instance, 
arachidonoylethanolamide (AEA or anandamide) is a 
PUFA-derived endocannabinoid that regulates fear (1), 
anxiety (3), pain sensation (4), energy balance, appetite, 
memory (5), sedation, and euphoria (6). AEA modulates 
dopamine levels in the nucleus accumbens (7, 8), a brain 
region of the striatum involved in reward processes (9). 
Moreover, inhibition of FAAH, the enzyme responsible 
for AEA degradation, enhances AEA-induced dopamine 
release in the nucleus accumbens of rats (8). Medium 
spiny neurons (MSNs) represent the major neuronal 
population within the nucleus accumbens (10) and con-
trol a wide array of functions, such as habit, motor con-
trol, reward, and motivation.
Docosahexaenoylethanolamide (DHEA or synaptamide), 
another NAE, demonstrates synaptogenic properties in the 
brain (11) and may reduce inflammation and pain (12–17). 
DHEA and other NAEs, such as palmitoylethanolamide 
(PEA) and oleoylethanolamide (OEA), are known to elevate 
PPAR transcriptional activity (18–20) and an increase in 
PPAR activity is one potential mechanism to explain their in-
fluence on neurological function. The DHEA precursor, 
DHA (22:6n-3), can be exogenously consumed from marine 
and seafood sources or endogenously synthesized from -
linolenic acid (18:3n-3) or other precursors within the n-3 
PUFA biosynthesis pathway (21). One of these precursors, 
tetracosahexaenoic acid (THA, 24:6n-3), was first identified 
as an unstable precursor to DHA in 1991 (22), but was later 
determined to also be a product of DHA (23, 24). Compared 
with other n-3 PUFAs, THA is present at low levels in various 
tissues and blood (23, 25–27) but appears to be higher in the 
brain (25, 27). The low levels of THA appear due to a short 
half-life and rapid turnover (23) and may suggest an impor-
tant role for THA in various tissues for the rapid conversion 
to metabolites important in biological functions. Previ-
ously, we demonstrated that unesterified DHA and ARA 
Abstract N-acylethanolamines (NAEs) are endogenous 
lipid-signaling molecules derived from fatty acids that regu-
late numerous biological functions, including in the brain. 
Interestingly, NAEs are elevated in the absence of fatty 
acid amide hydrolase (FAAH) and following CO2-induced 
ischemia/hypercapnia, suggesting a neuroprotective response. 
Tetracosahexaenoic acid (THA) is a product and precursor 
to DHA; however, the NAE product, tetracosahexaenoyletha-
nolamide (THEA), has never been reported. Presently, THEA 
was chemically synthesized as an authentic standard to con-
firm THEA presence in biological tissues. Whole brains were 
collected and analyzed for unesterified THA, total THA, and 
THEA in wild-type and FAAH-KO mice that were euthanized 
by either head-focused microwave fixation, CO2 + microwave, 
or CO2 only. PPAR activity by transient transfection assay 
and ex vivo neuronal output in medium spiny neurons 
(MSNs) of the nucleus accumbens by patch clamp electro-
physiology were determined following THEA exposure. 
THEA in the wild-type mice was nearly doubled (P < 0.05) 
following ischemia/hypercapnia (CO2 euthanization) and 
up to 12 times higher (P < 0.001) in the FAAH-KO compared 
with wild-type. THEA did not increase (P > 0.05) transcrip-
tional activity of PPARs relative to control, but 100 nM of 
THEA increased (P < 0.001) neuronal output in MSNs of the 
nucleus accumbens. Here were identify a novel NAE, THEA, 
in the brain that is elevated upon ischemia/hypercapnia and 
by KO of the FAAH enzyme. While THEA did not activate 
PPAR, it augmented the excitability of MSNs in the nucleus 
accumbens.  Overall, our results suggest that THEA is a novel 
NAE that is produced in the brain upon ischemia/hypercapnia 
and regulates neuronal excitation.
Supplementary key words  tetracosahexaenoic acid • fatty acid amide 
hydrolase • patch clamp • neurons • brain lipids • fatty acid • fatty acid/
metabolism  •  peroxisome  proliferator-activated  receptors  •  fatty  acid 
amide hydrolase-knockout
N-acylethanolamines (NAEs or fatty acid ethanolamines) 
are lipid-signaling molecules that play decisive roles in 
This article contains supplemental data.
‡These authors should be considered co-first authors.
*For correspondence: Adam H. Metherel, adam.metherel@utoronto.ca
Tetracosahexaenoylethanolamide, a novel  
N-acylethanolamide, is elevated in ischemia  
and increases neuronal output
Lin Lin1,‡, Adam H. Metherel1,‡,*, Mathieu Di Miceli2, Zhen Liu1, Cigdem Sahin3, Xavier Fioramonti2,  
Carolyn L. Cummins3, Sophie Layé2, and Richard P. Bazinet1
1Department of Nutritional Sciences, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada, 2Université de 
Bordeaux, INRA, Bordeaux INP, NutriNeuro, UMR 1286, Bordeaux, France, and 3Department of Pharmaceutical Sciences, 
University of Toronto, Toronto, Ontario, Canada
RESEARCH ARTICLE
This is an Open Access article under the CC BY license.
THEA identification in FAAH-KO and ischemic mouse brain 1481
were increased in mouse brain during periods of ischemia/
hypercapnia (28), and that this elevation was exacerbated 
in FAAH-KO mice. Furthermore, DHEA was increased in 
ischemic/hypercapnic wild-type and FAAH-KO mice, with 
FAAH-KO mice exhibiting up to four times higher levels of 
DHEA in the brain compared with wild-type mice (28).
To the best of our knowledge, a THA-derived tetracosa-
hexaenoylethanolamide (THEA) has not been characterized 
and may be a bioactive mediator. In our study, we chemi-
cally synthesized THEA as an authentic standard and devel-
oped a LC-MS/MS method to measure levels of THEA in 
vivo. Furthermore, we examined how ischemia/hypercapnia 
and deletion of the FAAH enzyme affected THEA and 
THA levels in the mouse brain, and then assessed the effects 
of THEA on neurotransmission by evaluating the response 
of accumbal  aminobutyric acid (GABA)ergic MSN to 
THEA exposure. We observed increased neuronal output 
in response to THEA exposure, suggesting a role for THEA 
in regulating neuronal excitability.
MATERIALS AND METHODS
Organic synthesis of DHEA and THEA
Methods for DHEA and THEA synthesis were adopted from 
Karaulov et al. (29). Briefly, DHA (Nu-Chek Prep, Inc., Elysian, 
MN) and THA methyl esters (Larodan, Inc., Monroe, MI) were 
treated with fresh monoethanolamine (1:5 molar ratio; Millipore-
Sigma, Burlington, MA) and trifluoroacetic acid (Millipore-
Sigma). The mixture was vortexed and heated at 140°C for 1 h, 
cooled to room temperature, and extracted with chloroform. 
Following addition of chloroform, the mixture was acidified by 
adding 10% aqueous HCl to a pH of 3, allowing for the formation 
of monoethanaolamine salts that could be then be separated in 
the aqueous phase from the THEA-containing chloroform layer. 
The lower chloroform layer was removed and the chloroform + 
HCl extraction was repeated. The combined chloroform frac-
tions were evaporated under a stream of nitrogen. The NAEs 
(DHEA or THEA) were further isolated by TLC and dissolved 
in ethanol for further analysis.
Separation and purification of THEA using HPLC
THEA separation and identification was performed using 
HPLC (Waters 2690, Boston, MA) with a Luna C18 reverse-phase 
column (4.6 × 250 mm, 100 Å; Phenomenex, Torrance, CA) 
equipped with an in-line UV photodiode array detector (Waters 
996), which monitors a wavelength of 242 nm. Briefly, solvent (A) 
(100% water) and solvent (B) (100% acetonitrile) were used at a 
1 ml/min gradient system, an isocratic mobile phase condition of 
95% (B) for 20 min and injection volume of 50 µl. All fractions 
were collected at 1 min intervals for a total of 20 min and then 
analyzed by liquid scintillation counting.
Identification and quantification of THEA using HPLC-MS
MS/MS was performed with a SCIEX QTrap5500 mass spectrom-
eter (SCIEX, Framingham, MA) with an Agilent 1290 HPLC system 
(Agilent Technologies, Santa Clara, CA) equipped with a Phe-
nomenex Kinetex XB-C18 column, 50.9 × 4.6 mm, 2.6 µm (Phe-
nomenex) and set to a flow rate of 600 l/min (28). The ion mass 
transitions used were as follows: DHEA (m/z 372.3/62.0), DHEA-d4 
(m/z 376.3/ 66.0), THEA (m/z 400.3/62). Peak integration and data 
analysis were performed using Analyst® software (SCIEX).
Animals
Animal experiments for FAAH-KO studies were performed in 
accordance with relevant guidelines and regulations of the Ani-
mal Care Committee of the University of Toronto (#20011517). 
FAAH-KO mice were obtained from Dr. Ben Cravatt, Department 
of Chemistry at Scripps Research Institute (La Jolla, CA). Brain 
samples were obtained from FAAH-KO and C57BL/6J wild-type 
mice as secondary analysis of our previously published study (28). 
Mice were housed in groups of four per cage with a 12:12 h 
light:dark cycle in a temperature-controlled (21°C) and humidity-
controlled (40%) environment, with ad libitum access to standard 
chow and water. At 12 weeks of age, animals were fasted for 12 h 
prior to euthanization. The animals (n = 8–9 per group) were 
randomly assigned to one of three euthanasia groups: i) head-fo-
cused, high energy microwave irradiation (microwave; 1 kW, 
0.88–0.99 s; Cober Electronics Inc., Stratford, CT); ii) CO2 + mi-
crowave (5 min CO2 then microwave fixation); or iii) CO2 only 
(CO2 5 min only). Whole brain required approximately 5 min per 
animal for removal, after which the brains were immediately 
stored at 80°C until further analysis.
Animal experiments for ex vivo whole-cell patch electrophysiol-
ogy were conducted in accordance with the European directive 
2010/63/UE and approved by the French Ministry of Research 
and the local ethics committee (CEEA Bordeaux N°55; APAFIS 
#50150171-A). Wild-type C57BL/6J mice were housed 8–10 per 
cage with a 12:12 h light:dark cycle in a temperature-controlled 
(23 ± 1°C) and humidity-controlled (40%) environment, with ad 
libitum access to standard chow and water. All experiments were 
conducted in compliance with ARRIVE guidelines.
Whole brain total THA extraction and GC-MS
Total lipid extracts (TLEs) were obtained from frozen powdered 
whole brain samples according to a modified Folch method (30) 
and similarly to previous studies performed in our laboratory (28). 
Briefly, lipids were extracted with 2:1 chloroform:methanol con-
taining a known amount of 2H8 (deuterated-6-8, D8)-arachidonic 
acid (20:4n-6) (Cambridge Isotope Laboratories, Inc., Tewksbury, 
MA) as an internal standard to determine THA concentration. The 
mixtures were vortexed, and 0.88% potassium chloride was added 
to separate solvent phases. The samples were then centrifuged at 
500 g for 10 min, and the lower lipid-containing chloroform layer 
was transferred to a new test tube and stored at 80°C. The TLE 
was aliquoted for separate total fatty acid and unesterified fatty acid 
analysis, as previously described (31). Briefly, for total fatty acids, 
the TLE portion was saponified with 10% potassium hydroxide in 
methanol (w:v), and the unesterified fatty acids were isolated by 
TLC with 60:40:2 (v:v:v) heptane:diethyl ether:acetic acid, bands 
scraped, and extracted with 2:1 chloroform:methanol. Following 
this, saponified total fatty acids and isolated unesterified fatty acids 
were converted to pentafluorobenzyl esters by heating at 60°C in 
1:10:1,000 (v:v:v) pentafluorobenzyl bromide:diisopropylamine:ac
etonitrile (32), dried under nitrogen gas, and dissolved in 100 l of 
hexane for GC-MS analysis. Total THA and unesterified THA were 
analyzed on an Agilent 5977A quadrupole mass spectrometer cou-
pled to an Agilent 7890B gas chromatograph (Agilent Technolo-
gies, Mississauga, ON, Canada) in negative chemical ionization 
mode. The details of the GC-MS set up were described previously 
(28, 32). In this study, THA was analyzed in selected ion monitor-
ing mode using M-1 for parent ion identification with ion dwell 
times of 500 ms. The parent ion mass (M – H+) for THA is 355.3.
THEA extraction in brain samples
THEA was extracted from powdered brain samples (28, 33). 
Briefly, samples were mixed with the 50 µl of DHEA-D4 (Cayman 
Chemical Co., Ann Arbor, MI; 50 ng/ml) as an internal standard. 
The mixture was prepared with ice-cold acetone, homogenized, and 
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centrifuged. The supernatant was transferred into a clean tube 
and dried under nitrogen gas. Chloroform:methanol:deionized 
water (2:1:1, v:v:v) was then added to the dried samples, vortexed, 
and centrifuged at 500 g for 10 min at 4°C. The chloroform layer 
was transferred into another clean tube, dried under nitrogen 
gas, and dissolved in 100 l of acetonitrile. Finally, samples were 
transferred into vials for LC-MS/MS analysis. THEA was identified 
by LC-MS/MS; as described earlier, THEA concentrations were 
determined using the DHEA-D4 as the internal standard.
Transient transfection assay
HEK293 cells were cultured in high-glucose DMEM (Sigma, 
Oakville, ON) containing 10% FBS and 1% penicillin/streptomycin 
at 37°C in 5% CO2. For transfection assays, cells were plated into 
a clear bottom white 96-well plate at a density of 40,000 cells per 
well in DMEM supplemented with 10% charcoal-stripped FBS 
(Invitrogen, Carlsbad, CA). The next day, cells were transfected 
with 150 ng/well of plasmid DNA mix (50 ng UAS-luciferase 
reporter, 20 ng -galactosidase, 15 ng human nuclear receptor 
GAL4-PPAR and 65 ng of pGEM filler plasmid) using calcium 
phosphate. Six hours after transfection, cells were treated with 
vehicle (DMSO), varying concentrations of THEA (including 10, 
25, and 50 M), endogenous fatty acid amide ligands or synthetic 
ligands as positive controls. All positive controls were purchased 
from Cayman Chemicals (Ann Arbor, MI). Endogenous fatty acid 
amide ligands were 25 M OEA and 25 M PEA. Synthetic li-
gands were 10 M WY14643 for PPAR, 25 M rosiglitazone for 
PPAR, and 100 nM GW0742 for PPAR/. The concentration 
of DMSO was held constant for all conditions at 0.1% (v/v). 
After14–16 h of ligand treatment to allow for complete luciferase 
translation and accumulation, cells were harvested and assayed 
for luciferase and -galactosidase activity. Luciferase values were 
corrected to the corresponding -galactosidase values to control 
for transfection efficiency and expressed as relative luciferase 
units. The plasmids were a kind gift from Dr. David Mangelsdorf 
(University of Texas Southwestern Medical Centre, Dallas, TX).
Ex vivo whole-cell patch clamp electrophysiology
Animals were anesthetized using isoflurane (4–5%). After rapid 
decapitation, sagittal slices were cut using a VT1000S vibratome 
(Leica, Germany) at a thickness of 350 m in ice-cold oxygenated 
artificial cerebrospinal fluid (ACSF), containing: 125 mM NaCl, 
2.5 mM KCl, 1.25 mM NaH2PO4, 2.0 mM CaCl2, 1.0 mM MgCl2, 25 
mM NaHCO3, 25 mM D-glucose, and 10 M pyruvic acid, pH 7.4, 
osmolarity 310 mOsm. Slices were then equilibrated at 33.5 ± 
0.1°C for 60 min before returning to room temperature. During 
recording, slices were continuously perfused at 1–1.5 ml/min 
with oxygenated buffer at 30°C. Borosilicate pipettes (5–6 M, 
1.5 mm OD; Sutter Instrument) were filled with an intracellular 
solution containing: 128 mM K-gluconate, 20 mM NaCl, 1 mM 
MgCl2, 1 mM EGTA, 0.3 mM CaCl2, 2 mM Na2-ATP, 0.3 mM Na-
GTP, 0.2 mM cAMP, 10 mM HEPES; 290–300 mOsM, pH 7.3–7.4. 
Pipette offset was adjusted before each recording. MSNs of the nu-
cleus accumbens core were visualized under direct interference 
contrast with 40× water immersion objective combined with an 
infra-red filter mounted on an upright BX51WI microscope (Olym-
pus, France). Recordings were acquired using Multiclamp700B 
and Digidata 1440A (Axon Instrument, Molecular Devices). Cur-
rent over voltage (I/V) curves were acquired in current-clamp 
mode without holding (I = 0). To evoke excitatory postsynaptic cur-
rents (EPSCs) at 0.1 Hz, a concentric bipolar electrode (Phymep, 
France) was placed on afferent glutamatergic fibers, recorded in 
MSNs under voltage-clamp configuration, with membrane poten-
tials maintained at 70 mV. Spontaneous EPSCs were recorded 
during 1 min under voltage-clamp configuration with membrane 
potentials held at 70 mV. To perform excitation-spike (E-S) 
coupling experiments, membrane potentials were held at 60 mV 
under current-clamp configuration with stimulations at 0.2 Hz. 
All data were sampled at 20 kHz and filtered at 1 kHz. Following 
10 min of baseline recording, either THEA (100 nM prepared in 
ACSF from concentrated stock THEA in ethanol) or vehicle [0.02% 
(v:v) ethanol in ACSF] were applied over a 20 min period, with 
measurements performed 20 min after THEA or vehicle washout. 
Only data from putative GABAergic MSN were included in the 
present study and identified immediately after rupture of the G 
seal by evaluating their responses to the injection of depolarizing 
currents, and is consistent with previous findings (34–36).
Statistics
All statistical analyses for THA and THEA were performed with 
GraphPad Prism 8.0.1. D’Agostino and Pearson omnibus nor-
mality tests for normality were conducted, and non-normally dis-
tributed data were log transformed prior to statistical analyses. 
Differences in total THA and unesterified THA concentrations 
were assessed by two-way ANOVA (genotype × euthanasia method) 
followed by Tukey’s multiple comparisons post hoc test. Due to 
the large differences in THEA levels between wild-type and FAAH-
KO mice, any real differences due to methods of euthanasia become 
lost with a two-way ANOVA model; therefore, one-way ANOVAs 
with Tukey’s multiple comparisons post hoc test to compare the 
effects of euthanasia methods within a genotype was performed 
for THEA. For the transient transfection assay, a one-way ANOVA 
followed by the Holm-Sidak test was performed for multiple com-
parisons against vehicle control group.
For electrophysiological experiments, all measurements were 
performed offline using Clampfit (Molecular Devices). For E-S 
coupling, the firing probability of a given neuron was plotted 
according to the EPSP slope, based on a previously published 
study (37). EPSP slopes were measured during the first 2.5 ms 
and spike probability was determined by establishing a survival 
curve where, for each measured slope, a spike was considered as 
an event. Significant differences in neuronal output were deter-
mined by the Log-rank (Mantel-Cox) test. Statistical significance 
was set as P < 0.05 for all analyses.
RESULTS
Verification of purity and identity of the synthesized 
DHEA and THEA
First, DHEA was synthesized and HPLC used to confirm 
the presence of the DHEA product and reagents (Fig. 1A) 
and compared with reference materials for commercially 
available reference standards of DHEA (Fig. 1B), DHA 
methyl ester (Fig. 1C), ethanolamine (reaction reagents) 
(Fig. 1D), and ethanol (reaction by-product) (Fig. 1E). 
The purified DHEA contained no traces of ethanolamine 
(Fig. 1D) or ethanol (Fig. 1E) but did contain trace 
amounts of DHA methyl ester (Fig. 1A). Therefore, we 
separated the synthesized DHEA from DHA ethyl ester by 
HPLC retention time.
THEA was then synthesized using THA methyl ester, and 
after checking for ethanolamine, THA methyl ester, and 
ethanol impurities, THEA was isolated and the purity con-
firmed by HPLC (Fig. 2A). The identity of the THEA was 
further confirmed by LC-MS/MS with mass transitions 
of m/z 400.3 and 61.9, representing the THEA parent 
ion and ethanolamine daughter ion, respectively (Fig. 2B). 
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Fig. 1. Representative HPLC chromatograms of DHEA and contaminants. Chromatograms of laboratory synthesized DHEA (A) compared 
with chromatograms for reference standards of commercially available DHEA (B), DHA methyl ester (C), ethanolamine (D), and ethanol (E).
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Mass transitions and retention time of our synthesized 
THEA standard (Fig. 2C) were used to accurately identify 
THEA in whole-brain samples from the mice.
CO2-induced ischemia/hypercapnia on whole-brain THA, 
unesterified THA, and THEA
There was an interaction effect between genotype and eu-
thanasia method on unesterified THA levels (Fig. 3A). The 
interaction effect showed that microwave fixation signifi-
cantly prevented the elevation of unesterified THA during 
ischemia/hypercapnia in both FAAH-KO and wild-type mice. 
CO2-induced ischemia/hypercapnia elevated unesterified 
THA levels in a step-up pattern as microwave < CO2 + micro-
wave < CO2 only in both genotypes. In addition, FAAH-KO 
mice in the CO2-only group had higher levels of unesterified 
THA compared with any other groups. FAAH-KO mice also 
had higher unesterified brain THA in the CO2 + microwave 
and CO2-only groups compared with wild-type mice. Total 
brain THA levels were not significantly affected by FAAH 
genotype or euthansia method (P > 0.05, Fig. 3B).
Fig. 2. Representative chromatograms and mass spectra of organically synthesized THEA following purification. HPLC chromatogram of syn-
thesized and purified THEA (A), LC-MS/MS mass spectra of synthesized THEA (B), and LC-MS/MS chromatogram of synthesized THEA (C).
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In the C57B/6J mice, both CO2 + microwave and CO2-
only groups had higher THEA levels compared with the 
microwave group (P = 0.0226) (Fig. 4A). Although the 
levels of THEA were significantly higher in the FAAH-KO 
mice compared with the C57B/6J mice, CO2-induced 
ischemia/hypercapnia did not affect the levels of THEA in 
the FAAH-KO mice (Fig. 4A), and this is further depicted 
with representative chromatograms of THEA from the 
CO2-only groups of the wild-type (Fig. 4B) and the FAAH-KO 
mice (Fig. 4C). Importantly, THEA could only be detected 
in two mice from each of the microwave and CO2 + micro-
wave groups, suggesting even lower brain THEA levels than 
we are reporting.
THEA does not activate the PPARs
OEA and PEA are long-chain fatty acid amides that have 
previously been shown to activate PPAR (both) or PPAR/ 
(OEA only) (18, 19). To assess whether THEA would also 
have activity at these receptors, we performed a transient 
transfection assay in HEK293 cells. The synthetic PPAR ag-
onists, WY14643, rosiglitazone, and GW0742, strongly acti-
vated human PPAR, PPAR, and PPAR/, respectively, 
demonstrating the functionality of the assay (Fig. 5). OEA 
and PEA induced the activity of PPAR (Fig. 5A), and OEA 
also weakly activated PPAR/ (Fig. 5C) while showing no 
activity toward PPAR (Fig. 5B). In contrast, PEA had no 
agonist effects on PPAR or PPAR/ (Fig. 5B, C), consis-
tent with previous studies (18, 19). THEA was tested at 10, 
25, and 50 M, and showed no activity toward any of the 
PPAR isoforms (Fig. 5).
THEA increases neuronal output of accumbal MSNs
Using whole-cell patch clamp electrophysiology on sagit-
tal slices, we recorded MSNs in the nucleus accumbens 
core (supplemental Fig. S1A). Compared with control con-
ditions (ethanol 0.02% v/v), we found no effect of THEA 
exposure (100 nM during 20 min) on the intrinsic electro-
physiological properties of MSNs, including resting mem-
brane potential, input resistance, and cell capacitance 
(supplemental Fig. S1B–D), or action potential properties, 
such as action potential threshold, amplitude, and dura-
tion (supplemental Fig. S1E–H). THEA did not alter either 
passive membrane potential (supplemental Fig. S1I, J) or 
the number of spikes (supplemental Fig. S1K) in response 
to current injections. However, THEA exposure signifi-
cantly increased the firing probability for a given neuron 
following afferent glutamatergic fiber stimulation (2 = 
15.27, Log-rank Mantel-Cox test, P < 0.0001; Fig. 6A–C), 
indicating increased excitability in these neurons. Indeed, 
while 50% spike probability was achieved at 6.1 mV/ms in 
control conditions, 4.9 mV/ms was sufficient after THEA 
exposure, denoting increased neuronal output.
DISCUSSION
To our knowledge, this is the first study to measure 
THEA and assess its function. As there was no commer-
cially available reference standard of THEA, we first con-
firmed that any signal obtained by MS was not the result of 
a molecule of identical mass and retention time. There-
fore, it was necessary to synthesize a THEA standard from 
accepted methodologies (29). Importantly, we first as-
sessed our synthesis protocol for DHEA so that we could 
compared it to a commercially available DHEA standard 
and were then able to synthesize and purify a THEA stan-
dard that could be used for accurate identification of 
THEA in mouse whole brain. Overall, results from whole 
brain of mice identified the presence of a novel NAE, 
THEA, in the brains of mice.
Whole-brain THEA levels were higher during ischemic/
hypercapnic conditions (CO2 + microwave and CO2-only 
euthanasia methods) compared with the nonischemic (mi-
crowave only) condition in the wild-type mice. This is simi-
lar to what we observed previously for DHEA, OEA, and 
AEA (28). Furthermore, THEA levels were 15- to 20-fold 
higher in the FAAH-KO mice compared with wild-type 
mice with no effect of the ischemia/hypercapnia in the 
Fig. 3. Ischemia/hypercapnia and FAAH-KO increases brain unesterified THA. Whole-brain concentrations 
of unesterified THA (A) and total THA (B) in wild-type (C57B/6J) and FAAH-KO mice following euthanasia 
by either head-focused microwave fixation (microwave), carbon dioxide (CO2) asphyxiation followed immedi-
ately by microwave (CO2 + microwave), or CO2 only. Different letters represent statistically different values 
between euthanasia method within genotype, and asterisks (*) represent statistically significant differences 
between genotype within a euthanasia method following two-way ANOVA (genotype × euthanasia method),  
P < 0.05. Following significant interaction effects, one-way ANOVAs followed by Tukey’s post hoc test were per-
formed to compare the effect of euthanasia method within genotype, and t-tests were performed comparing 
genotype within a euthanasia method, P < 0.05. Values are expressed as mean ± SEM, n = 8–9 per group.
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FAAH-KO animals. The elevated THEA in FAAH-KO 
matches very closely with our previous findings and sug-
gests that THEA is catabolized by FAAH similarly to other 
NAEs (28). The lack of any further increase in THEA levels 
in the ischemic/hypercapnic FAAH-KO mice suggests a po-
tential limit or ceiling for brain THEA levels. Although we 
can confidently quantify the levels of THEA in ischemic/
hypercapnic wild-type mice when euthanized by the CO2-
only method, THEA was only detectable in two nonisch-
emic mice (microwave method) and two partially ischemic 
mice (CO2 + microwave), and may limit some of our inter-
pretations. Nevertheless, by reporting the mean of the de-
tected samples, this leads to an overestimation of the true 
values, which in turn leads to an underestimation of the 
effect of ischemia/hypercapnia on THEA levels. There-
fore, our broad interpretation that ischemia/hypercapnia 
leads to an increase in brain THEA levels remains intact.
We showed no measurable change in the levels of total-
brain THA; however, unesterified THA levels increase upon 
ischemia/hypercapnia as shown previously with other fatty 
acids (28, 38), and this response appears to be exacerbated 
in the FAAH-KO mice. Unlike our previous findings where 
the increases in unesterified brain DHA was accompanied 
by similar increases in DHEA with ischemia/hypercapnia 
in the FAAH-KO animals (28), the increase in unesterified 
THA levels was not matched by a concomitant increase in 
THEA. This suggests a saturation in THEA synthesis, de-
spite continued increases in the unesterified THA precur-
sor, resulting from limitations in either the activity or level 
of the THEA-synthesizing process, and possibly N-acylphos-
phatidylethanolamine phospholipase D (39). Neverthe-
less, other enzymes capable of synthesizing or metabolizing 
NAEs, including monoacylglyceride lipase, acid cerami-
dase, and N-acylethanolamine-hydrolyzing acid amidase, 
may be differentially activated or regulated in the FAAH-
KO model; thus, additional studies are warranted to test 
these possible interactions in FAAH-KO mice.
It is also possible that a rapid conversion of THA to THEA 
is met (and exceeded under normal baseline conditions) 
by a similarly rapid metabolic consumption of THEA. Such 
a rapid metabolism of THEA is highlighted by our inability 
to identify the molecule above our limits of detection in all 
but two of the animals per microwave euthanasia group, 
and such rapid consumption by neural tissues indicates an 
important role for THEA in healthy neurological function-
ing. Future studies may be designed using intracerebroven-
tricular injections of THEA to determine the half-life in the 
brain compared with other NAEs, such as DHEA. Alterna-
tively, THA is rapidly converted to DHA in vivo (23), and if 
THEA synthesis is saturated, the excess unesterified THA 
in the brain could be used to synthesize additional DHA, 
and in turn DHEA. These are important molecules in neu-
roinflammation, as both unesterified DHA (40) and DHEA 
(41) are protective against lipopolysaccharide-induced 
neuroinflammation in rodent models.
Relative to the blood and other tissues, the brain has 
some of the highest levels of THA in the body (23, 25–27), 
and may therefore have added importance in neural tis-
sues. In our animals, total brain THA was at least 20 nmol/g 
across all conditions and is substantially higher than previ-
ous reports of 1–6 nmol/ml THA in rodent plasma (23, 26) 
and 1–3 nmol/ml in human plasma (42). This enrichment 
Fig. 4. Ischemia/hypercapnia and FAAH-KO increase brain 
THEA. A: Whole brain concentrations of THEA in wild-type 
(C57B/6J) and FAAH-KO mice following euthanasia by either 
head-focused microwave fixation (microwave), carbon dioxide 
(CO2) asphyxiation followed immediately by microwave (CO2 + 
microwave), or CO2 only. Different letters represent statistically 
different values between euthanasia method within genotype by 
one-way ANOVA (genotype × euthanasia method) followed by 
Tukey’s post hoc test, P < 0.05. Values are expressed as mean ± 
SEM, n = 8–9 per group, except C57B/6J mice of microwave and 
CO2 + microwave groups (n = 2) due to THEA being below the 
limit of detection in six to seven samples per group (see the Dis-
cussion for more details). LC-MS/MS chromatogram of whole-
brain THEA from wild-type CO2-only mouse (B) and LC-MS/MS 
chromatogram of whole-brain THEA from FAAH-KO CO2-only 
mouse (C).
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in brain THA could be due to either a higher rate of uptake 
into the brain or an increase in synthesis from n-3 PUFA 
precursors such as EPA (20:5n-3) and/or DHA (23, 31). To 
this point, cell lines originating from neural tissues, neuro-
blastoma (SK-N-SH) cells, and retinoblastoma (Y79) cells 
demonstrate strikingly different metabolism of DHA com-
pared with cells originating from nonneuronal tissues, 
hepatocarcinoma (HepG2) cells, and breast cancer (MCF7) 
cells (24). Specifically, when incubated with 13C-DHA over 
24 h, neural tissues preferred elongation of DHA to THA 
instead of the retroconversion/-oxidation to the EPA 
pathway that appears to dominate in the nonneuronal tis-
sues. This may support the hypothesis for a heightened de-
mand for THA in neural tissues and the brain, possibly as a 
pool for THEA synthesis.
PEA and OEA are known activators of PPAR (18, 19); 
OEA weakly activates PPAR/, and the n-3 PUFA-derived 
eicosapentaenoylethanolamide and DHEA have been shown 
activate PPAR in MCF7 cells (20). Furthermore, PPAR is 
not only activated in the brains of FAAH-KO mice (43), but 
a reversal of drug-induced inhibition of MSN excitability 
has previously been shown to involve PPAR activation 
without CB1 involvement (44). In addition, it has been 
reported that through PPAR activation, the resultant 
increase in neurosteroids may then act on GABA recep-
tors (45) that are highly abundant in MSNs (46). With 
the understanding that multiple NAEs activate PPARs, 
we sought to determine whether THEA would also show 
activity toward the PPARs. Although we confirmed the 
activity of PEA and OEA toward PPAR along with posi-
tive controls for PPAR, PPAR, and PPAR/, THEA 
showed no additional activity toward any of the PPARs 
in comparison to the vehicle.
MSNs represent the major neuronal population within the 
nucleus accumbens of the neostriatum (10). In our study, 
we assessed the effects of THEA on neuronal functioning in 
the MSNs of the nucleus accumbens and observed increased 
neuronal output following THEA exposure, indicating that 
THEA can modulate the extrinsic excitability of these neu-
rons. This increase in neuronal output of accumbal MSNs 
Fig. 5. THEA does not activate PPAR, PPAR/, or PPAR in a cotransfection assay. HEK293 cells were transfected with GAL4-hPPAR, 
GAL4-hPPAR, or GAL4-hPPAR/ and UAS-luciferase reporter plasmid. The values were normalized to vehicle control (DMSO). *P < 0.05 
versus vehicle (Veh) (DMSO); one-way ANOVA followed by Holm-Sidak test. The dashed line was set to 1 for ease of comparison. OEA, PEA, 
WY14643, rosiglitazone, and GA0742 were used as positive controls. Values are expressed as mean ± SD, n = 3 per group.
Fig. 6. THEA increases neuronal output of accumbal MSNs. (A) Representative drawing of a sagittal brain section in mice, with location 
of both glutamatergic fiber stimulation and MSN patch clamp recording. Dark gray, dorsal striatum; light gray, nucleus accumbens; A, ante-
rior; P, posterior; D, dorsal; V, ventral. B: Typical electrophysiological E-S coupling experiment where stimulations of afferent glutamatergic 
fibers evoke spiking in the recorded neurons. The depicted traces represent two typical recordings following 0.02% ethanol (control) or 100 
nM THEA exposures. The orange rectangle indicates stimulation occurrence, while the gray rectangle corresponds to the first 2.5 ms of 
neuronal responses where EPSC slopes (dV/dt) are measured. C: Significantly increased spike probability to stimulation in MSNs following 
THEA exposures (100 nM over 20 min), denoting increased excitability in these neurons. ****P < 0.0001 [Log-rank (Mantel-Cox) test]; n 
values represent sample number.
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appears to occur without altering intrinsic electrophysio-
logical properties. Such an increase in neuronal excitabil-
ity can directly modulate dopamine-dependent functions, 
such as motivation. Here, we found that THEA enhanced 
synaptic integration in accumbal MSNs. Ischemic condi-
tions are known to increase the excitability of striatal neu-
rons (47–51), and the neostriatum has been considered 
as one of the brain regions most susceptible to ischemia. 
Furthermore, it has been shown that neurotransmission is 
affected by ischemia through metabolites derived from 
linoleic acid (52), a PUFA from the n-6 family. Collectively, 
the increase in THA-derived THEA following ischemia/
hypercapnia and the ability of THEA to increase neuronal 
excitability suggests an important role for THEA during 
ischemia, particularly in the neostriatum. We therefore hy-
pothesize that THEA can be implicated in neuromodula-
tion during (or following) ischemic episodes in the brain. 
Furthermore, modes of increasing brain THA levels, pos-
sibly through diet (53), may be a means to further pro-
tect against ischemic episodes. With MSNs primarily being 
GABAergic in nature, future mechanistic studies might 
be designed to assess the effects of THEA on GABA re-
ceptors and GABAergic neurotransmission. Additional 
studies should assess whether THEA can modulate the activ-
ity of GABA neurons in other brain areas, and whether such 
effects are specific to GABA neuromodulation.
Current research on fatty acid and lipid metabolism 
involving THA and THEA is limited, with ours the first to 
ever report THEA. Our study has identified the presence 
of this novel endocannabinoid in mouse brain, its in-
crease in ischemic/hypercapnic and FAAH-KO mice, 
and its ability to increase neuronal output in MSNs. 
However, the mechanisms by which these changes occur 
are not clear and warrant further investigation. In con-
clusion, we have identified a novel NAE, THEA, which is 
mobilized during periods of ischemia/hypercapnia and 
when FAAH is absent, and that modulates the electrical 
activity of MSNs within the nucleus accumbens core, sug-
gesting an important physiological role that could be a 
target for future studies aimed at improving neurological 
functioning.
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